Welcome, Guest. Please login or register.
July 14, 2024, 12:09:38 am

Login with username, password and session length

  • Total Posts: 55130
  • Total Topics: 4851
  • Online Today: 42
  • Online Ever: 1314
  • (June 22, 2016, 05:23:42 am)
Users Online
Users: 0
Guests: 41
Total: 41


Welcome to the Hep Forums, a round-the-clock discussion area for people who have Fatty Liver Disease, Hepatitis B, C or a co-infection, their friends and family and others with questions about hepatitis and liver health. Check in frequently to read what others have to say, post your comments, and hopefully learn more about how you can reach your own health goals.

Privacy Warning: Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.
  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.
  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.
  • Product advertisement (including links); banners; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from the Hep Forum Moderators.
Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Hepatitis C Treatment Is Cost Effective for Genotypes 2 Through 5  (Read 6202 times)

0 Members and 1 Guest are viewing this topic.

Offline Hep Editors

  • Member
  • Posts: 784
    • Hep Mag
Treating hepatitis C virus (HCV) among those with genotypes 2 through 5 of the virus is largely cost-effective given current drug pricing and could even save money if such medications are heavily discounted.

Publishing their findings in Alimentary Pharmacology & Therapeutics, researchers conducted a systematic search of electronic databases for published studies that provided cost-effectiveness estimates for the treatment of genotypes 2 through 6 of hep C with direct-acting antivirals (DAAs).


Offline HHburme

  • Member
  • Posts: 117
  • Harvoni start 12/13/14 12wks UD/24wk DET
Re: Hepatitis C Treatment Is Cost Effective for Genotypes 2 Through 5
« Reply #1 on: August 06, 2018, 10:00:09 pm »
Hi Everybody. Hope all is well. Haven’t posted for awhile, but still SVR. I had a rough journey too, fails Harvoni and was tested for resistance, which I was. There are many new drugs for us that are RAV. I had a mutated NS5A. Was lucky to get into a Gilead trial that finally worked, and the med is now available. Vosevi is the name of the drug.
Anyone who is resistant to DAA, this may be the med for you. So never give up, feels so good to have the dragon gone. Love to all.
infected age 19, blood transfusion 1977, detected 2003  GT 1a, Harvoni relapse 06/15, Clinical Trial Study for SOF/VEL GS-9857 start 02/16. SVR12 Cured 08/16


© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.